Skip to main content
SpringerLink
Log in

Serum Metabonomics Analysis of Fuzi Lizhong Decoction for the Treatment of Splenasthenic Syndrome

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Fuzi lizhong decoction (FLD) derives from an ancient Chinese Pharmacopoeia: San Yin Ji Bing Zheng Fang Lun, composed of equal amounts of Aconitum carmichaeli Debeaux (ACD); Zingiber officinale Roscoe (ZOR); Glycyrrhiza uralensis Fisch. (GUF); Atractylodes macrocephala Koidz. (AMK); and Codonopsis pilosula Franch. (CPF). Its pill has been used for the treatment of gastrointestinal disorders for years. The objective of this study was to clarify the curative effect of FLD on splenasthenic syndrome and to identify biomarkers upon which FLD acts as a therapeutic agent based on a serum metabonomics analysis. Serum samples from a blank group (BG), a model group (MG), and a treatment group (TG) of rats were analyzed using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS). Then, both the endogenous metabolites and metabolic pathways in the MG samples versus the BG samples were investigated. A partial least squares discriminant analysis (PLS-DA) was used to separate MG from BG and to filter the different endogenous metabolites between the two groups. Furthermore, analysis of variance (ANOVA) was used to select potential biomarkers that significantly differed in MG compared with those in BG to evaluate their callback situation in TG. Compound identification was performed based on retention time, accurate mass weight, and MS/MS spectra by searching online databases and references. The results showed that 166 of 1189 total detected ions were different between MG and BG according to the variable importance plot (VIP) values (>1.5) obtained through partial least squares discriminate analysis (PLS-DA), 62 of which were detected in positive mode and 104 of which were detected in negative mode. Fifteen compounds, including L-palmitoylcarnitine, 11Z-octadecenylcarnitine, LysoPC(14:0), LysoPC(16:1(9Z)), LysoPC(P-18:0), LysoPE(20:0/0:0), LysoPC(18:2(9Z,12Z)), LysoPC(18:1(9Z)), LysoPC(18:0), LysoPC(20:2(11Z,14Z)), LysoPC(20:0), uric acid, 2-phenylethanolglucuronide, LysoPC(15:0), and LysoPC(16:0), were identified and considered biomarkers of splenasthenic syndrome. Among them, LysoPC(15:0), LysoPC(16:0), L-palmitoylcarnitine, 11Z-octadecenylcarnitine, LysoPC(16:1(9Z)), and LysoPC(P-18:0) were retrieved after rats were cured with FLD in TG, and the related pathways involving fatty acid degradation and glycerophospholipid metabolism were identified. This experiment confirmed that FLD may treat splenasthenic syndrome by improving fatty acid degradation and glycerophospholipid metabolism and is expected to be developed as a beneficial pharmaceutical for the spleen.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Zheng XF, Tian JS, Liu P, Xing J, Qin XM (2014) Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using 1H-NMR-based metabonomics. J Ethnopharm 151:912–920

    Article  Google Scholar 

  2. Chen LH, Yang ZM, Chen WW, Li RL, Lin CQ, Guan LH, Zhu ZZ, Chen RF, Li S, Zhao LB, Zeng JH, Wang JH (2015) Differential expression of immune-related genes between healthy volunteers and type 2 diabetic patients with spleen-deficiency pattern. J Trad Chin Med 35:646–652

    Article  Google Scholar 

  3. Xiong B, Qian H (2013) Effects of Sijunzi decoction and Yupingfeng powder on expression of janus kinase-signal transducer and activator of transcription signal pathway in the brain of spleen-deficiency model rats. J Trad Chin Med 33:78–84

    Article  Google Scholar 

  4. Duan YQ, Cheng WD, Cheng YX, Li HY, Li XY, Zhu LM, Yang XY (2013) Variations of energy metabolism and adenosine Triphosphatase activity in gastric mucosa in chronic atrophic gastritis rats with Qi deficiency and blood stasis syndrome and effect of Zhiweifangbian capsule. J Trad Chin Med 33:500–504

    Article  Google Scholar 

  5. Dou XB, Tang HQ, Zhang HS, Li KM (2013) The impact of Lizhong decoction on spleen deficiency rat axonal transport and adenylate transferase activity. J Youjiang méd Coll For Natly 35:348–349

    Google Scholar 

  6. Tang HQ (2012) Influences of fuzi lizhong decoction on blood sugar, triglyceride and total cholesterol in rats with spleen yang deficiency syndrome. Chin J Exp Tradit méd Formulae 18:230–233

    Google Scholar 

  7. Liu M, Zhou YB, Sun SL, Yang WL, Jin YX, Li X (2012) Fuzi lizhong decoction in the treatment of gastric ulcer of spleen-stomach deficiency cold type. Acta Chin Med Pharmacol 40:42–44

    Google Scholar 

  8. Wei Y, Tang HQ, Li XH, Zhu XY (2013) Effects of Fuzi Lizhong Decoction on Immune Cell Factors in Rats with Spleen Yang Deficiency Syndrome. Chin J Exp Tradit méd Formulae 19:179–182

    CAS  Google Scholar 

  9. Xie WJ, Zhang ZM, Wu ZJ (2013) Impact of Fuzilizhong Decoction on TNF-α and IL-10 in Rats Serum with Diarrhea-predominant Irrita-ble Bowel Syndrome. J Emerg Tradit Chin Med 22:1287–1288

    Google Scholar 

  10. Huang Q, Tan YX, Yin PY, Zhou LN, Ye GZ, Lu X, Wang HY, Xu GW (2013) Metabolic characterization of hepatocellular carcinoma using non-targeted tissue metabonomics. Metabolic Cancer Res 73:4992–5002

    Article  CAS  Google Scholar 

  11. Xu XB, Gao BB, Guan QJ, Zhang DD, Ye XH, Zhou L, Tong GX, Li H, Zhang L, Tian JK, Huang JY (2016) Metabolomic profile for the early detection of coronary artery disease by using UPLC-QTOF/MS. J Pharm Biomed Anal 129:34–42

    Article  CAS  Google Scholar 

  12. Huang Y, Bo YH, Wu X, Wang QY, Qin F, Zhao LS, Xiong ZL (2016) An intergated serum and urinary metabonomic research based on UPLC-MS and therapeutic effects of Gushudan on prednisolone-induced osteoporosis rats. J Chromatogr B 1027:119–130

    Article  CAS  Google Scholar 

  13. Gong YG, Liu Y, Zhou L, Di X, Li W, Li Q, Bi K (2015) A UHPLC-TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model. J Pharm Biomed Anal 115:174–182

    Article  CAS  Google Scholar 

  14. Li SJ, Lin H, Qu C, Tang YP, Shen J, Li WX, Yue SJ, Kai J, Shang GX, Zhu ZH, Zhang CB, Liu P, Yan H, Zhang L, Qian L, Qian DW, Duan JA (2015) Urine and plasma metabonomics coupled with UHPLC-QTOF/MS and multivariate data analysis on potential biomarkers in anemia and hematinic effects of herb pair. J Ethnopharm 170:175–183

    Article  CAS  Google Scholar 

  15. Zhong LP, Cheng F, Lu XY, Duan YX, Wang XD (2016) Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Talanta 158:351–360

    Article  CAS  Google Scholar 

  16. Zavodskaya IS, Khodzhaev BR (1964) The mechanism of reserpine ulcers of the stomach. Bull Exp Biol Med 57:196–198

    Article  Google Scholar 

  17. Li SQ, Shi DY, Li PF, Li X, Tang XG, Guo SN (2010) The impact of modified sijunzi decoction on blood circulation and biochemical indicators of spleen dogs. Heilongjiang Animal Sci Vet Med 8:150–152

    Google Scholar 

  18. Zhang XJ, Wang LJ, Tuvdendor D, Wu ZP (2013) Acute hyperinsulinemia and reduced plasma free fatty acid levels decrease intramuscular triglyceride synthesis. Metabolism 62:44–51

    Article  CAS  Google Scholar 

  19. Marisela OM, Diego HE, Rolando HM (2013) α-Tocopherol administration blocks adaptive changes in cell NADH/NAD+ redox state and mitochondrial function leading to inhibition of gastric mucosa cell proliferation in rats. Free Radical Biol Med 65:1090–1100

    Article  Google Scholar 

  20. Schmitz G, Rurbsaamen K (2010) Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 208:10–18

    Article  CAS  Google Scholar 

  21. Yu M, Cui FX, Jia HM, Zhou C, Yang Y, Zhang HW, Ding G, Zou ZM (2016) Aberrant purine metabolism in allergic asthma revealed by plasma metabonomics. J Pharm Biomed Anal 120:181–189

    Article  CAS  Google Scholar 

  22. Petru L, Pavelcova K, Sebesta I, Stiburkova B (2016) Genetic background of uric acid metabolism in a patient with severe chronic tophaceous gout. Clin Chim Acta 460:46–49

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Y. Xin wishes to express her gratitude for help from colleagues at Analysis and Testing Center, Chemistry and Chemical Engineering College, Qiqihar University. This study was supported by the National Natural Science Foundation of China (No. 81403067) and Heilongjiang Province Science and Technology Department (No. 12541874).

Author information

Authors and Affiliations

  1. College of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar, 161006, China

    Yang Xin

  2. College of Adult and Continuing Education, Qiqihar Medical University, Qiqihar, 161006, China

    Haijun Wang

Authors
  1. Yang Xin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haijun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haijun Wang.

Ethics declarations

Ethical Standards

This study was approved by the Ethics Committee of Beijing Vital River Laboratory Animal Technology Co., Ltd. [SYXK (Beijing) 2012–0024] and complied with all national and international guidelines for research involving animals. After the experiments, all rats were euthanized with CO2 under anesthesia to alleviate suffering.

Conflict of interest

There are no potential conflicts of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xin, Y., Wang, H. Serum Metabonomics Analysis of Fuzi Lizhong Decoction for the Treatment of Splenasthenic Syndrome. Chromatographia 80, 1047–1059 (2017). https://doi.org/10.1007/s10337-017-3308-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-017-3308-0

Keywords

Search

Navigation